APYX MEDICAL CORP (APYX) Institutional Ownership Changes & 13F Activity
APYX MEDICAL CORP (APYX). Institutional ownership data tracks hedge funds, asset managers, and other institutional investors based on recent SEC Form 13F filings (Q2 2026). This page analyzes institutional buying and selling activity, new holdings, and sold-out positions in the latest reporting period. Notable filers include Royce & Associates Lp, Sei Investments Co, Renaissance Technologies LLC, Ubs Group Ag, and Marshall Wace, Llp.
| Institution | Type | Change in shares | Change Position % | Shares | Reported stock balance | Portfolio quarter | Filing date |
|---|---|---|---|---|---|---|---|
| Citadel Advisors Llc | Buy | +60,546 | +56.2% | 168,344 | $755.86K | Q2 2026 | Sep 02, 2026 |
| Nantahala Capital Management, Llc | Sell | -170,056 | -4.9% | 3,270,248 | $14.68M | Q2 2026 | Aug 19, 2026 |
| Kingsview Wealth Management, Llc | Buy | +5,500 | +2.6% | 214,288 | $962.15K | Q2 2026 | Aug 19, 2026 |
| Jefferies Financial Group Inc. | Buy | +24,500 | — | 24,500 | $110.00K | Q2 2026 | Aug 17, 2026 |
| Royce & Associates Lp | Buy | +662,840 | +25.4% | 3,274,064 | $14.70M | Q2 2026 | Aug 14, 2026 |
| Sei Investments Co | Sell | -317,226 | -53.0% | 281,029 | $1.26M | Q2 2026 | Aug 14, 2026 |
| Archon Capital Management Llc | Sell | -146,206 | -5.2% | 2,644,717 | $11.87M | Q2 2026 | Aug 14, 2026 |
| Qube Research & Technologies Ltd | Sell | -68,736 | -85.5% | 11,652 | $52.32K | Q2 2026 | Aug 14, 2026 |
| Susquehanna International Group, Llp | Sell | -51,298 | -19.2% | 216,263 | $971.02K | Q2 2026 | Aug 14, 2026 |
| Jane Street Group, Llc | Sell | -40,526 | -30.9% | 90,771 | $407.56K | Q2 2026 | Aug 14, 2026 |
| Squarepoint Ops Llc | Buy | +32,144 | — | 32,144 | $144.33K | Q2 2026 | Aug 14, 2026 |
| Goldman Sachs Group Inc | Sell | -29,535 | -40.0% | 44,388 | $199.30K | Q2 2026 | Aug 14, 2026 |
| Millennium Management Llc | Sell | -19,395 | -7.4% | 242,663 | $1.09M | Q2 2026 | Aug 14, 2026 |
| Exoduspoint Capital Management, Lp | Buy | +14,069 | — | 14,069 | $63.17K | Q2 2026 | Aug 14, 2026 |
| Point72 Asset Management, L.P. | Sell | -8,428 | -24.2% | 26,350 | $118.31K | Q2 2026 | Aug 14, 2026 |
| Xtx Topco Ltd | Buy | +7,243 | +31.4% | 30,340 | $136.23K | Q2 2026 | Aug 14, 2026 |
| Caption Management, Llc | Sell | -2,748 | -1.5% | 183,003 | $821.68K | Q2 2026 | Aug 14, 2026 |
| Osaic Holdings, Inc. | Sell | -2,400 | -16.7% | 12,000 | $53.88K | Q2 2026 | Aug 14, 2026 |
| Royal Bank Of Canada | Sell | -659 | -13.7% | 4,162 | $19.00K | Q2 2026 | Aug 14, 2026 |
| Barclays Plc | Sell | -87 | -19.8% | 352 | $1.58K | Q2 2026 | Aug 14, 2026 |
| Renaissance Technologies LLC | Buy | +251,883 | +83.3% | 554,278 | $2.49M | Q2 2026 | Aug 13, 2026 |
| Ubs Group Ag | Sell | -218,594 | -94.5% | 12,751 | $57.25K | Q2 2026 | Aug 13, 2026 |
| Marshall Wace, Llp | Buy | +174,630 | +282.4% | 236,466 | $1.06M | Q2 2026 | Aug 13, 2026 |
| Informed Momentum Co Llc | Sell | -75,965 | -30.8% | 170,470 | $765.41K | Q2 2026 | Aug 13, 2026 |
| Kanen Wealth Management Llc | Buy | +74,900 | — | 74,900 | $336.30K | Q2 2026 | Aug 13, 2026 |
| Northern Trust Corp | Sell | -32,882 | -29.5% | 78,567 | $352.77K | Q2 2026 | Aug 13, 2026 |
| Dauntless Investment Group, Llc | Buy | +30,249 | — | 30,249 | $135.82K | Q2 2026 | Aug 13, 2026 |
| Acadian Asset Management Llc | Buy | +23,145 | +45.0% | 74,555 | $327.00K | Q2 2026 | Aug 13, 2026 |
| Centiva Capital, Lp | Buy | +22,533 | +54.9% | 63,554 | $285.36K | Q2 2026 | Aug 13, 2026 |
| Vanguard Fiduciary Trust Co | Buy | +21,340 | +10.5% | 224,021 | $1.01M | Q2 2026 | Aug 13, 2026 |
Frequently asked questions about APYX activity
Which institutional owners are buying APYX?
Institutional owners buying APYX include investors who have either initiated new positions or increased their existing holdings based on recent SEC 13F filings. The activity table above highlights which funds added shares in the latest reporting periods and how their positions changed over time.
What does "buy" mean in APYX activity?
"Buy" means an investor increased their reported position in APYX compared to the prior reporting period. This reflects growing exposure to APYX MEDICAL CORP (APYX) rather than necessarily a brand-new position (though new positions also appear as buys when prior quantity was zero).
Is institutional interest in APYX increasing?
Institutional interest in APYX can be assessed by comparing the number of tracked funds adding or increasing positions versus those trimming or exiting across the periods shown. A higher number of additions typically signals increasing participation among large filers, but it should be read alongside position sizes and the full table.
Related APYX Institutional Insights
- APYX Overview
- APYX 13F Institutional Holders
- APYX Top Institutional Shareholders
- Healthcare Sector Institutional Ownership
- Healthcare Sector Portfolio Overlap
- Institutional Portfolio Overlap & Shared Holdings
- Most Bought Healthcare Stocks By Institutional Investors
- Most Sold Healthcare Stocks By Institutional Investors
- APYX Insider Trading & SEC Form 4 Activity
- APYX Articles
- Top Institutional Investor Stock Rankings